643
Views
1
CrossRef citations to date
0
Altmetric
Articles

Acute kidney function and morphology following topload administration of recombinant hemoglobin solution

, , , , , & show all
Pages 24-30 | Received 29 Jul 2016, Accepted 23 Sep 2016, Published online: 31 Oct 2016

References

  • Abraham B, Hicks W, Jia Y, Baek JH, Miller JL, Alayash AI. 2011. Isolated Hb Providence beta82Asn and beta82Asp fractions are more stable than native HbA(0) under oxidative stress conditions. Biochemistry 50:9752–9766.
  • Abramoff MD, Magalhães PJ, Ram SJ. 2004. Image Processing with ImageJ. Biophotonics Int 11:36–42.
  • Beeri R, Symon Z, Brezis M, Ben-Sasson SA, Baehr PH, Rosen S, Zager RA. 1995. Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys. Kidney Int 47:1806–1810.
  • Bian Y, Rong Z, Chang TM. 2011. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant. Artif Cells Blood Substitut Immobil Biotechnol 39:127–136.
  • Bolton-Maggs P, Poles D. 2014. Participation in UK Haemovigilance Reporting; [Internet]. [cited 2016 Jun 19]. Available from: http://www.shotuk.org/wp-content/uploads/report-2014.pdf.
  • Bonaventura J, Bonaventura C, Sullivan B, Ferruzzi G, McCurdy PR, Fox J, Moo-Penn WF. 1976. Hemoglobin providence. Functional consequences of two alterations of the 2,3-diphosphoglycerate binding site at position beta 82. J Biol Chem 251:7563–7571.
  • Bunn HF, Jandl JH. 1968. Exchange of heme among hemoglobins and between hemoglobin and albumin. J Biol Chem243:465–475.
  • Burhop K, Gordon D, Estep T. 2004. Review of hemoglobin-induced myocardial lesions. Artif Cells Blood Substit Immobil Biotechnol 32:353–374.
  • Cable R, Carlson B, Chambers L, Kolins J, Murphy S, Tilzer L, et al. 2007. Practice guidelines for blood transfusion: a compilation from recent peer-reviewed literature [Internet]. American Red Cross [cited 2016 Jul 7]. Available from: http://www.sld.cu/galerias/pdf/sitios/anestesiologia/practical_guidelines_blood_transfusion.pdf.
  • Chan WL, Tang NL, Yim CC, Lai FM, Tam MS. 2000. New features of renal lesion induced by stroma free hemoglobin. Toxicol Pathol 28:635–642.
  • Chang TM. 1971. Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehyde. Biochem Biophys Res Commun 44:1531–1536.
  • DeVenuto F, Zegna A. 1982. Blood exchange with pyridoxalated and polymerized hemoglobin solution. Surg Gynecol Obstet 155:342–346.
  • Doherty DH, Doyle MP, Curry SR, Vali RJ, Fattor TJ, Olson JS, Lemon DD. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat Biotechnol 1998. 16:672–676.
  • Dou Y, Maillett DH, Eich RF, Olson JS. 2002. Myoglobin as a model system for designing heme protein based blood substitutes. Biophys Chem 98:127–148.
  • Dudziak R, Bonhard K. 1980. The development of haemoglobin preparations for various indications. Anaesthesist 29:181–189.
  • Endrich B, Asaishi K, Gotz A, Messmer K 1980. . Technical report – a new chamber technique for microvascular studies in unanesthetized hamsters. Res Exp Med (Berl) 177:125–134.
  • Gundersen SI, Chen G, Palmer AF. 2009. Mathematical model of NO and O2 transport in an arteriole facilitated by hemoglobin based O2 carriers. Biophys Chem 143:1–17.
  • Huang H, Olsen KW. 1994. Thermal stabilities of hemoglobins crosslinked with different length reagents. Artif Cells Blood Substitut and Immobil Biotechnol 22:719–724.
  • Lacy ER, Schmidt-Nielsen B. 1979. Ultrastructural organization of the hamster renal pelvis. Am J Anat 155:403–423.
  • Landers DF, Hill GE, Wong KC, Fox IJ. Blood transfusion-induced immunomodulation. Anesth Analg 1996;82:187–204.
  • Lemon DD, Boland EJ, Nair PK, Olson JS, Hellums JD. 1988. Effects of physiological factors on oxygen transport in an in vitro capillary system. Adv Exp Med Biol 222:37–44.
  • Loeb A, McIntosh LJ, Raj NR, Longnecker D. 1997. Regional vascular effects of rHb1.1, a hemoglobin-based oxygen carrier. J Cardiovasc Pharmacol 30:703–710.
  • Looker D, Abbott-Brown D, Cozart P, Durfee S, Hoffman S, Mathews AJ, et al. 1992. A human recombinant haemoglobin designed for use as a blood substitute. Nature 356:258–260.
  • Looker D, Mathews AJ, Neway JO, Stetler GL. Expression of recombinant human hemoglobin in Escherichia coli. Methods Enzymol 1994. 231:364–374.
  • Moo-Penn WF, Jue DL, Bechtel KC, Johnson MH, Schmidt RM. 1976. Hemoglobin Providence. A human hemoglobin variant occurring in two forms in vivo. J Biol Chem 251:7557–7562.
  • Olson JS, Foley EW, Rogge C, Tsai AL, Doyle MP, Lemon DD. 2004. No scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic Biol Med 36:685–697.
  • Page TC, Light WR, McKay CB, Hellums JD. 1998. Oxygen transport by erythrocyte/hemoglobin solution mixtures in an in vitro capillary as a model of hemoglobin-based oxygen carrier performance. Microvasc Res 55:54–64.
  • Paller MS. 1988. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol 255:F539–F544.
  • Palmer AF, Intaglietta M. 2014. Blood substitutes. Annu Rev Biomed Eng 16:77–101.
  • Przybelski RJ, Daily EK, Kisicki JC, Mattia-Goldberg C, Bounds MJ, Colburn WA. 1996. Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution. Crit Care Med 24:1993–2000.
  • Rohlfs RJ, Bruner E, Chiu A, Gonzales A, Gonzales ML, Magde D, et al. 1998. Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J Biol Chem 273:12128–12134.
  • Sakai H, Hara H, Yuasa M, Tsai AG, Takeoka S, Tsuchida E, Intaglietta M. 2000. Molecular dimensions of Hb-based O(2) carriers determine constriction of resistance arteries and hypertension. Am J Physiol Heart Circul Physiol 279:H908–H915.
  • Schock-Kusch D, Sadick M, Henninger N, Kraenzlin B, Claus G, Kloetzer HM, et al. 2009. Transcutaneous measurement of glomerular filtration rate using FITC-sinistrin in rats. Nephrol Dial Transplant 24:2997–3001.
  • Schock-Kusch D, Xie Q, Shulhevich Y, Hesser J, Stsepankou D, Sadick M, et al. 2011. Transcutaneous assessment of renal function in conscious rats with a device for measuring FITC-sinistrin disappearance curves. Kidney Int 79:1254–1258.
  • Schreiber A, Shulhevich Y, Geraci S, Hesser J, Stsepankou D, Neudecker S, et al. 2012. Transcutaneous measurement of renal function in conscious mice. Am J Physiol Renal Physiol 303:F783–F788.
  • Stramer SL. 2007. Current risks of transfusion-transmitted agents: a review. Arch Pathol Lab Med 131:702–707.
  • Tsai AG, Cabrales P, Manjula BN, Acharya SA, Winslow RM, Intaglietta M. 2006. Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers. Blood 108:3603–3610.
  • Tsai AG, Friesenecker B, McCarthy M, Sakai H, Intaglietta M. 1998. Plasma viscosity regulates capillary perfusion during extreme hemodilution in hamster skinfold model. Am J Physiol 275:H2170–H2180.
  • Tsai AG, Intaglietta M, Sakai H, Delpy E, La Rochelle CD, Rousselot M, Zal F. 2012. Microcirculation and NO-CO studies of a natural extracellular hemoglobin developed for an oxygen therapeutic carrier. Curr Drug Discov Technol 9:166–172.
  • Tuinman PR, Vlaar AP, Cornet AD, Hofstra JJ, Levi M, Meijers JC, et al. 2011. Blood transfusion during cardiac surgery is associated with inflammation and coagulation in the lung: a case control study. Crit Care 15:R59.
  • Varnado CL, Mollan TL, Birukou I, Smith BJ, Henderson DP, Olson JS. 2013. Development of recombinant hemoglobin-based oxygen carriers. Antioxid Redox Signal 18:2314–2328.
  • Vermeulen Windsant IC, de Wit NC, Sertorio JT, van Bijnen AA, Ganushchak YM, Heijmans JH, et al. 2014. Hemolysis during cardiac surgery is associated with increased intravascular nitric oxide consumption and perioperative kidney and intestinal tissue damage. Front Physiol 5:340.
  • Von Stark G. 1898. Die resorborbarkeirt des haimatins und die bedeutungder hemoglobinpreparate. Dtsche Med Wochenschr 24:805–808.
  • Yu B, Bloch KD, Zapol WM. Hemoglobin-based red blood cell substitutes and nitric oxide. Trends Cardiovasc Med 2009. 19:103–107.
  • Yu B, Raher MJ, Volpato GP, Bloch KD, Ichinose F, Zapol WM. 2008. Inhaled nitric oxide enables artificial blood transfusion without hypertension. Circulation 117:1982–1990.
  • Yu B, Shahid M, Egorina EM, Sovershaev MA, Raher MJ, Lei C, et al. 2010. Endothelial dysfunction enhances vasoconstriction due to scavenging of nitric oxide by a hemoglobin-based oxygen carrier. Anesthesiology 112:586–594.
  • Zollner FG, Schock-Kusch D, Backer S, Neudecker S, Gretz N, Schad LR. 2013. Simultaneous measurement of kidney function by dynamic contrast enhanced MRI and FITC-sinistrin clearance in rats at 3 tesla: initial results. PLoS One 8:e79992.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.